ES436028A1 - Un procedimiento de atenuacion del virus de la rinotraquei- tis viral felina virulenta. - Google Patents

Un procedimiento de atenuacion del virus de la rinotraquei- tis viral felina virulenta.

Info

Publication number
ES436028A1
ES436028A1 ES436028A ES436028A ES436028A1 ES 436028 A1 ES436028 A1 ES 436028A1 ES 436028 A ES436028 A ES 436028A ES 436028 A ES436028 A ES 436028A ES 436028 A1 ES436028 A1 ES 436028A1
Authority
ES
Spain
Prior art keywords
feline
production
feline rhinotracheitis
tissue cultures
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES436028A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Veterinary Inc
Original Assignee
Pitman Moore Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pitman Moore Inc filed Critical Pitman Moore Inc
Publication of ES436028A1 publication Critical patent/ES436028A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265Infectious rhinotracheitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES436028A 1974-03-25 1975-03-25 Un procedimiento de atenuacion del virus de la rinotraquei- tis viral felina virulenta. Expired ES436028A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45434574A 1974-03-25 1974-03-25

Publications (1)

Publication Number Publication Date
ES436028A1 true ES436028A1 (es) 1978-06-01

Family

ID=23804244

Family Applications (1)

Application Number Title Priority Date Filing Date
ES436028A Expired ES436028A1 (es) 1974-03-25 1975-03-25 Un procedimiento de atenuacion del virus de la rinotraquei- tis viral felina virulenta.

Country Status (12)

Country Link
JP (1) JPS50154415A (cs)
AT (1) AT340583B (cs)
AU (1) AU502636B2 (cs)
BE (1) BE827157A (cs)
CA (1) CA1058074A (cs)
CH (1) CH618091A5 (cs)
DE (1) DE2512903A1 (cs)
ES (1) ES436028A1 (cs)
FR (1) FR2265405B1 (cs)
GB (1) GB1462545A (cs)
NL (1) NL7503499A (cs)
ZA (1) ZA751854B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
DE2544510A1 (de) * 1975-10-04 1977-04-14 Philips Nv Virales rhinotracheitisvakzin fuer das katzengeschlecht und verfahren zu dessen herstellung
FR2327799A1 (fr) * 1975-10-17 1977-05-13 Philips Nv Vaccin contre la rhinotracheite virale des felides et procede pour le preparer
US4031204A (en) * 1976-03-30 1977-06-21 Norden Laboratories, Inc. Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
JPS60196187A (ja) * 1984-03-16 1985-10-04 Biseibutsu Kagaku Kenkyusho:Kk 牛のrsウイルス弱毒株

Also Published As

Publication number Publication date
FR2265405A1 (cs) 1975-10-24
DE2512903A1 (de) 1975-10-02
JPS50154415A (cs) 1975-12-12
CH618091A5 (en) 1980-07-15
CA1058074A (en) 1979-07-10
GB1462545A (en) 1977-01-26
BE827157A (fr) 1975-09-25
AU502636B2 (en) 1979-08-02
NL7503499A (nl) 1975-09-29
AU7944675A (en) 1976-09-30
FR2265405B1 (cs) 1978-07-28
AT340583B (de) 1977-12-27
ZA751854B (en) 1976-10-27
ATA219075A (de) 1977-04-15

Similar Documents

Publication Publication Date Title
DE2964276D1 (en) Live attenuated human hepatitis-a-virus, method for growing it in cell culture in vitro and composition comprising it
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
DE3064259D1 (en) Vaccine for preventing persistent feline leukemia viremia in cats and process for preparing it
ES436028A1 (es) Un procedimiento de atenuacion del virus de la rinotraquei- tis viral felina virulenta.
JPS55153723A (en) Manufacture of influenza virus vaccine in liquid cell culture
ES486442A0 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
ES459086A1 (es) Procedimiento de obtencion de nuevas aril (trifluoretil) a- minas.
DE2962921D1 (en) Feline infectious peritonitis vaccine and process for its preparation
ES466758A1 (es) Un procedimiento de preparacion de un virus sincitial respi-ratorio atenuado.
Parkman et al. Development and characterization of a live attenuated rubella virus
GB846755A (en) Bovine rhinotracheitis vaccine and methods of production
Smith et al. Persistent rubella virus production in embryonic rabbit chondrocyte cell cultures
GB1436323A (en) Cell and virus culture systems
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
JPS5423191A (en) Preparation of cholin-oxydase by fermentation
JPS5338617A (en) Preparation of hepatitis-b vaccine
JPS5444094A (en) Preparation of phospholipase by fermentation
JPS5282786A (en) Preparation of l-serine by fermentation
GB1498821A (en) Vaccines
JPS5746923A (en) Inactivated vaccine for dog parvoviral infectious disease
IT1041774B (it) Vaccino per la rinotracheite virale die felini e metodo per la sua preparazione
FR2327799A1 (fr) Vaccin contre la rhinotracheite virale des felides et procede pour le preparer
NL7511136A (en) Prodn. of attenuated feline rhinotracheitis virus - for vaccine prepn.
Budowsky et al. Principles of selective inactivation of the viral genome. III. Kinetic of bacteriophage MS 2 infectivity inactivation by beta-propiolactone.